Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada · Delayed Price · Currency is CAD 5.04
-0.04 (-0.79%)
Jul 21, 2026, 4:00 PM EST
Medexus Pharmaceuticals Employees
Medexus Pharmaceuticals had 90 employees as of March 31, 2026. The number of employees decreased by 1 or -1.10% compared to the previous year.
Employees
90
Change (1Y)
-1
Growth (1Y)
-1.10%
Revenue / Employee
1.54M CAD
Profits / Employee
-37.13K CAD
Market Cap
160.84M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 90 | -1 | -1.10% |
| Mar 31, 2025 | 91 | 9 | 10.98% |
| Mar 31, 2024 | 82 | -16 | -16.33% |
| Mar 31, 2023 | 98 | -2 | -2.00% |
| Mar 31, 2022 | 100 | 76 | 316.67% |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascend Wellness Holdings | 2,300 |
| Organigram Global | 1,120 |
| TerrAscend | 1,038 |
| Aurora Cannabis | 1,028 |
| Cannara Biotech | 452 |
| Auxly Cannabis Group | 446 |
| HLS Therapeutics | 85 |
| Cardiol Therapeutics | 18 |
Medexus Pharmaceuticals News
- 25 days ago - Medexus Pharmaceuticals Earnings Call Transcript: Q4 2026 - Transcripts
- 25 days ago - Medexus Pharmaceuticals Earnings release: Q4 2026 - Filings
- 25 days ago - Medexus Pharmaceuticals Registration statement: Q4 2026 - Filings
- 25 days ago - Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection - Newsfile Corp
- 5 weeks ago - Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call - Newsfile Corp
- 6 weeks ago - Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada - Newsfile Corp
- 2 months ago - Medexus Pharmaceuticals Transcript: 16th Annual LD Micro Invitational Conference - Transcripts
- 3 months ago - Medexus Pharmaceuticals Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference - Transcripts